Dr Sarah Sheridan is a Technical Consultant at Merck, providing scientific, technical and regulatory consultancy within the BioReliance ® Biosafety Testing business of Merck. Drawing on over 30 years of experience in the human and animal health biotech industries, Dr Sheridan provides biosafety testing consultancy for the company’s global client base to support pre-clinical to commercial phase biosafety testing of client manufactured products spanning monoclonal antibodies to vaccines and novel gene therapies. Dr Sheridan has a Ph.D. in Veterinary Virology from the University of Cambridge, UK and a B.Sc. Honours degree in Life Science.